Peter Lipsky - F1000 Head of Faculty (since 14 December 2005)
Charlottesville, Charlottesville, VA, USA
BIOGRAPHY
Peter Lipsky M.D.Academic positions:
- Chief of the Autoimmunity Branch, Bethesda from 1999 to 2008
- Scientific Director of the Intramural Research Program at Bethesda from 1999 to 2004
- Dr Lipsky was at the University of Texas Southwestern Medical Center, Dallas from 1975 to 1999, holding the position of Director of the Harold C. Simmons Arthritis Research Center and the Rheumatic Diseases Division from 1984 to 1999.
Any Industry positions (last five years):
None declared
Research interests:
Dr Lipsky's current major research interests are B-cell biology, both in normal and autoimmune disease settings, and the generation of the immunoglobulin repertoire.
Dr Lipsky is internationally recognized for his research, particularly his work on T cell-macrophage interactions, the mechanisms of immune cell activation, the role of B cells in autoimmune diseases, and for his role in the development of novel therapeutics for rheumatoid arthritis.
Any other information:
Dr Lipsky is a fellow of the American Association for the Advancement of Science and The Royal College of Physicians. He is a member of the American Society for Clinical Investigation and the Association of American Physicians. He is a fellow of the Royal Academy of Physicians of Ireland.
Dr Lipsky is Editor-in-Chief of Arthritis Research and Therapy, Nature Reviews Rheumatology and serves on the editorial boards of numerous scientific journals. He is also past Editor-in-Chief of The Journal of Immunology (1992-1997).
He has been awarded numerous prizes, including the 2001 Carol Nachman Prize and the 2002 American College of Rheumatology Distinguished Investigator Award. In 2002, the Arthritis Foundation awarded Dr Lipsky the prestigious Lee Howley prize for his contributions, which represent a significant advance in the understanding, treatment and prevention of arthritis and rheumatic diseases.
What I think of the idea behind F1000M:
Up-to-date access to the latest scientific information is essential for successful investigation and clinical care.